Locations
South San Francisco, CA, USA
industry
Biotechnology
Size
51 - 200 employees
Stage
Series C+
founded in
2018
Star Therapeutics is a biotechnology company with a mission to develop life-changing therapies for as many rare diseases as possible for the millions of patients in urgent need. Our innovation engine starts with identifying multiple rare diseases that share a common biology and then discovering novel therapeutics that can treat these diseases with a single therapy. Star consists of a family of companies, each focusing on a specific area of novel biology and developing first-in-class antibody therapeutics. Electra Therapeutics, the first company within our portfolio to be unveiled, is developing therapies that target Signal Regulatory Proteins (SIRP) for the treatment of immunological diseases and cancer.
Something looks off?On-site & Remote